Scholars@Duke

• Background
• 

  Education, Training, & Certifications

  • Fellow in Hematology and Oncology, Medicine, Icahn School of Medicine at Mount Sinai 2004 - 2007
  • Medical Resident, Medicine, Icahn School of Medicine at Mount Sinai 2001 - 2004
  • M.D., University of Medicine and Dentistry of New Jersey 2001
• 

  Duke Appointment History

  • Assistant Professor of Medicine, Medicine, Medical Oncology, Medicine 2007 - 2013
  • Instructor, Temporary in the Department of Medicine, Medicine, Medical Oncology, Medicine 2007
• Research
• 

  Selected Grants

  • MOST awarded by Incyte Corporation 2017 - 2027
  • Protocol A5481082: POLARIS awarded by Pfizer, Inc. 2017 - 2022
  • REVEAL awarded by Incyte Corporation 2014 - 2018
• Publications & Artistic Works
• 

  Selected Publications

  • Conference Papers

    • Irwin, B, Kimmick, G, Altomare, I, Marcom, PK, Houck, K, Zafar, SY, and Peppercorn, J. "Patient experience and attitudes toward addressing the cost of breast cancer care." November 2014.  Full Text

  • Journal Articles

    • Chino, F, Peppercorn, JM, Rushing, C, Nicolla, J, Kamal, AH, Altomare, I, Samsa, G, and Zafar, SY. "Going for Broke: A Longitudinal Study of Patient-Reported Financial Sacrifice in Cancer Care." Journal of Oncology Practice 14, no. 9 (September 2018): e533-e546.  Full Text
    • Zullig, LL, Kimmick, G, Smith, V, Little, K, Bosworth, HB, Gonzales, S, Oakes, MM, Shelby, RA, Owen, L, and Altomare, IP. "Using a geriatric oncology assessment to link with services (GOAL)." Journal of Geriatric Oncology (June 26, 2018).  Full Text
    • Chino, F, Peppercorn, JM, Rushing, C, Kamal, AH, Altomare, I, Samsa, G, and Zafar, SY. "Out-of-Pocket Costs, Financial Distress, and Underinsurance in Cancer Care." Jama Oncology 3, no. 11 (November 2017): 1582-1584.  Full Text
    • Li, S, Molony, JT, Cetin, K, Wasser, JS, and Altomare, I. "Rate of bleeding-related episodes in elderly patients with primary immune thrombocytopenia: a retrospective cohort study." Current Medical Research and Opinion (August 24, 2017): 1-8.  Full Text
    • Lin, J, Zhang, X, Li, X, Chandler, D, Altomare, I, Wasser, JS, and Cetin, K. "Cost of Bleeding-related Episodes in Adult Patients With Primary Immune Thrombocytopenia: A Population-based Retrospective Cohort Study of Administrative Claims Data for Commercial Payers in the United States." Clinical therapeutics 39, no. 3 (March 2017): 603-609.e1.  Full Text
    • Altomare, I, Irwin, B, Zafar, SY, Houck, K, Maloney, B, Greenup, R, and Peppercorn, J. "Physician Experience and Attitudes Toward Addressing the Cost of Cancer Care." Journal of Oncology Practice 12, no. 3 (March 2016): e281-248.  Full Text
    • Cines, DB, Gernsheimer, T, Wasser, J, Godeau, B, Provan, D, Lyons, R, Altomare, I, Wang, X, and Lopez, A. "Integrated analysis of long-term safety in patients with chronic immune thrombocytopaenia (ITP) treated with the thrombopoietin (TPO) receptor agonist romiplostim." International journal of hematology 102, no. 3 (September 2015): 259-270.  Full Text
    • Zafar, SY, Chino, F, Ubel, PA, Rushing, C, Samsa, G, Altomare, I, Nicolla, J, Schrag, D, Tulsky, JA, Abernethy, AP, and Peppercorn, JM. "The utility of cost discussions between patients with cancer and oncologists." The American journal of managed care 21, no. 9 (September 2015): 607-615.
    • Liu, Y, Starr, MD, Brady, JC, Rushing, C, Bulusu, A, Pang, H, Honeycutt, W, Amara, A, Altomare, I, Uronis, HE, Hurwitz, HI, and Nixon, AB. "Biomarker signatures correlate with clinical outcome in refractory metastatic colorectal cancer patients receiving bevacizumab and everolimus." Molecular cancer therapeutics 14, no. 4 (April 2015): 1048-1056.  Full Text
    • Nussbaum, N, and Altomare, I. "The neoadjuvant treatment of rectal cancer: a review." Current oncology reports 17, no. 3 (March 2015): 434-. (Review)  Full Text
    • Selleslag, D, Bird, R, Altomare, I, Giagounidis, A, Janssens, A, Pabinger, I, Pullarkat, V, Wei, H, and Kreuzbauer, G. "Impact of self-administration of romiplostim by patients with chronic immune thrombocytopenia compared with administration by a healthcare provider." European journal of haematology 94, no. 2 (February 2015): 169-176.  Full Text
    • Bestvina, CM, Zullig, LL, Rushing, C, Chino, F, Samsa, GP, Altomare, I, Tulsky, J, Ubel, P, Schrag, D, Nicolla, J, Abernethy, AP, Peppercorn, J, and Zafar, SY. "Patient-oncologist cost communication, financial distress, and medication adherence." Journal of Oncology Practice 10, no. 3 (May 2014): 162-167.  Full Text
    • Showalter, K, Maize, J, Altomare, I, and Fisher, G. "Multiple myeloma diagnosed secondary to analysis of a lytic bone lesion encountered during mohs micrographic surgery." Dermatology Online Journal 19, no. 8 (August 21, 2013).
    • Altomare, I, and Hurwitz, H. "Everolimus in colorectal cancer." Expert Opinion on Pharmacotherapy 14, no. 4 (2013): 505-513.  Full Text
    • Showalter, K, Jr, JM, Altomare, I, and Fisher, G. "Multiple myeloma diagnosed secondary to analysis of a lytic bone lesion encountered during mohs micrographic surgery." Dermatology Online Journal 19, no. 8 (2013).
    • Uronis, HE, Bendell, JC, Altomare, I, Blobe, GC, Hsu, SD, Morse, MA, Pang, H, Zafar, SY, Conkling, P, Favaro, J, Arrowood, CC, Cushman, SM, Meadows, KL, Brady, JC, Nixon, AB, and Hurwitz, HI. "A phase II study of capecitabine, oxaliplatin, and bevacizumab in the treatment of metastatic esophagogastric adenocarcinomas." The Oncologist 18, no. 3 (January 2013): 271-272.  Full Text
    • Altomare, I, Wasser, J, and Pullarkat, V. "Bleeding and mortality outcomes in ITP clinical trials: A review of thrombopoietin mimetics data." American Journal of Hematology 87, no. 10 (2012): 984-987.  Full Text
    • Altomare, I, Bendell, JC, Bullock, KE, Uronis, HE, Morse, MA, Hsu, SD, Zafar, SY, Blobe, GC, Pang, H, Honeycutt, W, Sutton, L, and Hurwitz, HI. "A phase II trial of bevacizumab plus everolimus for patients with refractory metastatic colorectal cancer." The Oncologist 16, no. 8 (January 2011): 1131-1137.  Full Text
    • Hilari, JM, Mangas, C, Xi, L, Paradelo, C, Ferrándiz, C, Hughes, SJ, Yueh, C, Altomare, I, Gooding, WE, and Godfrey, TE. "Molecular staging of pathologically negative sentinel lymph nodes from melanoma patients using multimarker, quantitative real-time RT-PCR." Annals of Surgical Oncology 16, no. 1 (2009): 177-185.  Full Text
    • Altomare, I, Adler, A, and Aledort, LM. "The 5, 10 methylenetetrahydrofolate reductase C677T mutation and risk of fetal loss: A case series and review of the literature." Thrombosis Journal 5 (2007).  Full Text
    • Altomare, I, Desman, G, and Aledort, LM. "Echinocytosis - An unusual manifestation of hemangioma." American Journal of Hematology 81, no. 7 (2006): 532-534.  Full Text
    • Lapointe, R, Royal, RE, Reeves, ME, Altomare, I, Robbins, PF, and Hwu, P. "Retrovirally transduced human dendritic cells can generate T cells recognizing multiple MHC class I and class II epitopes from the melanoma antigen glycoprotein 100." Journal of Immunology 167, no. 8 (2001): 4758-4764.
    • Cetin, K, Altomare, I, Wetten, S, and Wasser, J. "Rate of bleeding-related episodes in adult patients with primary immune thrombocytopenia: a retrospective cohort study using a large administrative medical claims database in the US (Published online)." Clinical Epidemiology : 231-231.  Full Text

Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.